What if channel

Learn more about organizing work in channels. To help keep discussions organized, use threads. Learn some other ways to collaborate effectively in channels. Thanks so much for your feedback! Got it! Was this article helpful? Yes, thanks! The subjects could be science, common questions or even videos explaining if something actually happened in a recent trend.

He does some research and tends to explain a lot about the topic. On this channel, they explain how to survive various life-threatening situations. On this channel, they explain what happens when they push their bodies into their limits in various ways.

On this channel, they present distinctive features of animals. It was originally a show on Facebook and Snapchat, but later it got moved to YouTube. Chinese version came to YouTube on , but it's no longer active. How do I create a YouTube channel? First you will need a Google account. And as per the section above, if your child is under 13 you will need to use your information to create the channel.

Go to the YouTube homepage and log in via your Google account. Check the privacy settings There are three different settings for videos published on YouTube: Public, Private and Unlisted. Public: A default setting that allows any YouTube user to view the video Private: Allows you to restrict your video to be viewed by only yourself and other users that you select Unlisted: Only people who have the link to the video can view it. The video will not show up on your channel page or come up in any YouTube search filter To change video privacy settings Sign in to YouTube Studio From the left sidebar, select Videos Hover over the video you'd like to update.

Stay informed - safety news straight to your inbox. First Name. Last Name. Diaz, A. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Heart J. DiFrancesco, D. Pacemaker mechanisms in cardiac tissue. The funny current: cellular basis for the control of heart rate. Drugs 67 Suppl. CrossRef Full Text. Cardiac pacemaker If current: physiological and pharmacological properties.

Google Scholar. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science , — Direct activation of cardiac pace maker channels by intracellular cyclic AMP. Dominguez-Rodriguez, A. Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World J. Duhme, N. Altered HCN4 channel C-linker interaction is associated with familial tachycardia bradycardia syndrome and atrial fibrillation. Fang, L. A clinical perspective of anti-fibrotic therapies for cardiovascular disease.

FDA Fedorov, S. Antifibrotic effects of Ivabradine for myocardium in ischemic chronic heart failure. Pharma Innov. Fox, K. Ivabradine in stable coronary artery disease without clinical heart failure. Lancet , — Freemantle, N. Beta blockade after myocardial infarction: systematic review and meta-regression analysis. BMJ , — Gillman, M. Influence of heart rate on mortality among persons with hypertension: the Framingham study.

Izzo, P. Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Acute Cardiovasc. Care 1, — Jiang, G. Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes. Kannel, W. Heart rate and cardiovascular mortality: the Framingham study.

Laish-Farkash, A. Lang, C. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms. Atherosclerosis , 1—8. Ludwig, A. Zipes and J. Jalife Philadelphia, PA: Saunders , 59— Milliez, P. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.

Heart Circ. Nawathe, P. Ng, F. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia—reperfusion-induced ventricular arrhythmias. Parker, J. Nitrate therapy for stable angina pectoris. Pepine, C. Pfeffer, M. Ventricular remodeling after myocardial infarction.

Experimental observations and clinical implications. Circulation 81, — Poole-Wilson, P. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment ACTION trial : randomized controlled trial.

Rayner, B. Acetylcholine and potassium movements in rabbit auricles. Reil, J. Heart rate reduction in cardiovascular disease and therapy. Ruzyllo, W. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomized double-blind, multicentre, non-inferiority trial. Drugs 67, — Sakmann, B.